Thoroughness of Staging and the Outcomes of Surgical Resection Outcomes in Potentially Curable Non-Small Cell Lung Cancer (NSCLC)

被引:1
|
作者
Smeltzer, M. [1 ]
Lee, Y. [1 ]
Faris, N. [2 ]
Ray, M. [1 ]
Fehnel, C. [3 ]
Houston-Harris, C. [3 ]
Ojeabulu, P. [3 ]
Akinbobola, O. [3 ]
Deese, L. [4 ]
Owen, E. [5 ]
Wolf, B. [6 ]
Wiggins, H. [7 ]
Mutrie, C. [6 ]
Sachdev, V. [8 ]
Levy, P. [9 ]
Signore, R. [10 ]
Robbins, E. [3 ]
Osarogiagbon, R. [11 ]
机构
[1] Univ Memphis, Sch Publ Hlth, Epidemiol & Biostat, Memphis, TN 38152 USA
[2] Baptist Mem Healthcare, Baptist Canc Ctr, Memphis, TN USA
[3] Baptist Canc Ctr, Multidisciplinary Thorac Oncol Program, Thorac Oncol Res Grp, Memphis, TN USA
[4] Baptist North Mississippi, Thorac Surg, Oxford, MS USA
[5] Methodist North, Thorac Surg, Memphis, TN USA
[6] Baptist Desoto, Thorac Surg, Desoto, MS USA
[7] St Bernards Reg Med Ctr, Thorac Surg, Jonesboro, AR USA
[8] North Mississippi Med Ctr, Thorac Surg, Tupelo, MS USA
[9] Nea Baptist, Thorac Surg, Jonesboro, AR USA
[10] Baptist Canc Ctr, Multidisciplinary Thorac Oncol Clin, Memphis, TN USA
[11] Baptist Canc Ctr, Multidisciplinary Thorac Oncol Program, Memphis, TN USA
关键词
Thoroughness of staging; Surgical resection; survival;
D O I
10.1016/j.jtho.2017.09.419
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
OA 15.08
引用
收藏
页码:S1787 / S1787
页数:1
相关论文
共 50 条
  • [41] Patient Outcomes following Curative-Intent Lung Resection among Non-Small Cell Lung Cancer (NSCLC) Patients in China
    Zhou, Jian
    Wu, Eric Q.
    Yang, Fan
    Xie, Jipan
    Han, Simeng
    Wang, Xun
    Song, Huaying
    Wang, Jun
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S677 - S677
  • [42] The Outcomes of a Limited Resection for Non-Small Cell Lung Cancer Based on Differences in Pathology
    Yano, Motoki
    Yoshida, Junji
    Koike, Terumoto
    Kameyama, Kotaro
    Shimamoto, Akira
    Nishio, Wataru
    Yoshimoto, Kentaro
    Utsumi, Tomoki
    Shiina, Takayuki
    Watanabe, Atsushi
    Yamato, Yasushi
    Watanabe, Takehiro
    Takahashi, Yusuke
    Sonobe, Makoto
    Kuroda, Hiroaki
    Oda, Makoto
    Inoue, Masayoshi
    Tanahashi, Masayuki
    Adachi, Hirofumi
    Saito, Masao
    Hayashi, Masataro
    Otsuka, Hajime
    Mizobuchi, Teruaki
    Moriya, Yasumitsu
    Takahashi, Mamoru
    Nishikawa, Shigeto
    Matsumura, Yuki
    Moriyama, Satoru
    Fujii, Yoshitaka
    WORLD JOURNAL OF SURGERY, 2016, 40 (11) : 2688 - 2697
  • [43] The Outcomes of a Limited Resection for Non-Small Cell Lung Cancer Based on Differences in Pathology
    Motoki Yano
    Junji Yoshida
    Terumoto Koike
    Kotaro Kameyama
    Akira Shimamoto
    Wataru Nishio
    Kentaro Yoshimoto
    Tomoki Utsumi
    Takayuki Shiina
    Atsushi Watanabe
    Yasushi Yamato
    Takehiro Watanabe
    Yusuke Takahashi
    Makoto Sonobe
    Hiroaki Kuroda
    Makoto Oda
    Masayoshi Inoue
    Masayuki Tanahashi
    Hirofumi Adachi
    Masao Saito
    Masataro Hayashi
    Hajime Otsuka
    Teruaki Mizobuchi
    Yasumitsu Moriya
    Mamoru Takahashi
    Shigeto Nishikawa
    Yuki Matsumura
    Satoru Moriyama
    Yoshitaka Fujii
    World Journal of Surgery, 2016, 40 : 2688 - 2697
  • [44] Outcomes of sublobar and lobar resection for stage 1 non-small cell lung cancer
    Ahmed, Syeda-Saba
    Abid, Qamar
    Satur, Christopher
    Ghosh, Shilajit
    Hussain, Imran
    Bikmalla, Shiva
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [45] Outcomes of Surgical Treatment for Stage IV Non-Small Cell Lung Cancer (NSCLC) in a Population-Based Cohort
    Akinbobola, O.
    Minhas, A.
    Ogbeide, O.
    Faris, N.
    Fehnel, C.
    Saulsberry, A.
    Dortch, K.
    Matthews, A.
    Smeltzer, M. P.
    Ray, M. A.
    Osarogiagbon, R. U.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S594 - S595
  • [46] Uniportal VATS for Diagnosis and Staging in Non-Small Cell Lung Cancer (NSCLC)
    Del Campo, Jone Miren
    Maroto, Sergio
    Sebastian, Leyre
    Vaillo, Xavier
    Bolufer, Sergio
    Lirio, Francisco
    Sesma, Julio
    Galvez, Carlos
    DIAGNOSTICS, 2023, 13 (05)
  • [47] Role for surgical resection in the multidisciplinary treatment of stage IIIB non-small cell lung cancer (NSCLC).
    Bott, Matthew
    Patel, Aalok
    Crabtree, Traves
    Morgensztern, Daniel
    Robinson, Cliff Grant
    Colditz, Graham A.
    Waqar, Saiama Naheed
    Kreisel, Daniel
    Krupnick, Alexander Sasha
    Patterson, G. Alexander
    Broderick, Stephen R.
    Meyers, Bryan F.
    Puri, Varun
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [48] Comparative clinical and economic outcomes of treatments for refractory non-small cell lung cancer (NSCLC)
    Carlson, Josh J.
    Reyes, Carolina
    Oestreicher, Nina
    Lubeck, Deborah
    Ramsey, Scott D.
    Veenstra, David L.
    LUNG CANCER, 2008, 61 (03) : 405 - 415
  • [49] Clinical outcomes in immunotherapy and chemotherapy in minority populations with non-small cell lung cancer (NSCLC).
    Shin, Sang Ha
    Gonzalez, Teresita
    Raez, Luis E.
    Samuels, Shenae
    Razi, Syed
    Hussein, Atif Mahmoud
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [50] Outcomes of Nivolumab in Advanced Non-Small Cell Lung Cancer (NSCLC) in A Regional Australian Population
    Kasherman, Lawrence
    Brungs, Daniel
    Bell, Graeme
    Glasgow, Amanda L.
    Tafreshi, Ali
    Clingan, Philip
    Aghmesheh, Morteza
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 145 - 146